Emory School of Medicine
Dr. Zelnak received her BS with Highest Distinction in Biology with the Highest Honors from the University of North Carolina at Chapel Hill. She then earned her MD, Cum Laude from the Emory University School of Medicine. Dr. Zelnak completed her internal medicine residency at the Emory University School of Medicine. Following her internal medicine residency, Dr. Zelnak continued with her education in becoming a specialist in the medical oncology field. She completed her Hematology and Medical Oncology Fellowship at the Winship Cancer Institute at the Emory University School of Medicine. Dr. Zelnak is well respected in the medical community and has been invited to speak at several national conferences on the subject of breast cancer, including early stage, triple-negative, and metastatic breast cancer. Dr. Zelnak is also published in several medical industry publications. Dr. Zelnak is board certified in Internal Medicine, Medical Oncology and Hematology.
Dr. Zelnak’s research focuses on breast cancer in the areas of current clinical research including neoadjuvant chemotherapy for early-stage breast cancer, novel therapies for triple negative breast cancer (estrogen receptor, progesterone receptor, and Her2neu receptor negative).
View publications on PubMed
View clinical trials at Winship Cancer Institute